New antibiotics clindamycin, cephaloglycin, carbenicillin.
D000284:Administration, Oral; D000667:Ampicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D002228:Carbenicillin / Q000627:therapeutic use*; D002507:Cephaloglycin / Q000627:therapeutic use*; D002512:Cephalothin / Q000627:therapeutic use*; D002981:Clindamycin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000517:prevention & control; D006801:Humans; D008034:Lincomycin / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*; D013449:Sulfonamides / Q000009:adverse effects; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D010406:Penicillins; D013449:Sulfonamides; D002981:Clindamycin; D000667:Ampicillin; D008034:Lincomycin; D002228:Carbenicillin; D002507:Cephaloglycin; D002512:Cephalothin